Xconomy: Indiana top stories News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More	Ben Fidler	04/19/19	National
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants	Ben Fidler	04/18/19	Boston
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy	Ben Fidler	04/15/19	National
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout	Ben Fidler	04/12/19	New York
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More	Alex Lash	04/12/19	National
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices	Frank Vinluan	04/09/19	National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More	Frank Vinluan	04/05/19	National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results	Ben Fidler	04/03/19	National
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More	Ben Fidler	03/29/19	National
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More	Alex Lash	03/22/19	National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More	Frank Vinluan	03/15/19	National
Drug-Price Watchdog ICER Dives into Trump-Fueled Pharma Rebate Debate	Alex Lash	03/13/19	National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski	Ben Fidler	03/11/19	National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More	Alex Lash	03/08/19	National
Two Years and Done: FDA Commissioner Gottlieb To Resign	Alex Lash	03/05/19	National
Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount	Frank Vinluan	03/04/19	Indiana
Retailers Turn to Analytics, 3D Tech to Promote Fit, Reduce Returns	Angela Shah	03/04/19	National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark	Ben Fidler	03/01/19	National
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away	Alex Lash	02/26/19	National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More	Frank Vinluan	02/22/19	National
Bayer Snaps Up Rights to Two Cancer Drugs from Lilly’s $8B Loxo Deal	Frank Vinluan	02/15/19	Indiana
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More	Alex Lash	02/15/19	National
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans	Ben Fidler	02/12/19	National
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More	Ben Fidler	02/08/19	National
NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell	Ben Fidler	02/07/19	New York
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More	Frank Vinluan	02/01/19	National
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test	Ben Fidler	01/30/19	National
Plymouth Growth Partners Backs Fort Wayne’s Allied Payment Network	Sarah Schmid Stevenson	01/22/19	Detroit Ann Arbor
Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo	Frank Vinluan	01/18/19	Indiana
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer	Ben Fidler	01/18/19	National
Page 1 of 22	next page »